Home Cart Sign in  
Chemical Structure| 1797989-42-4 Chemical Structure| 1797989-42-4

Structure of Laduviglusib monohydrochloride
CAS No.: 1797989-42-4

Chemical Structure| 1797989-42-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Laduviglusib monohydrochloride is a selective GSK-3 inhibitor with high affinity for GSK-3α and GSK-3β, with IC50 values of 2.2 nM and 1.5 nM, respectively. Laduviglusib has neuroprotective and anticancer effects and can be used in research on Alzheimer's disease and cancer.

Synonyms: CT99021 monohydrochloride; CHIR-99021 Monohydrochloride; CT99021 HCl

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Laduviglusib monohydrochloride

CAS No. :1797989-42-4
Formula : C22H19Cl3N8
M.W : 501.80
SMILES Code : N#CC1=CN=C(NCCNC2=NC=C(C3=NC=C(C)N3)C(C4=CC=C(Cl)C=C4Cl)=N2)C=C1.[H]Cl
Synonyms :
CT99021 monohydrochloride; CHIR-99021 Monohydrochloride; CT99021 HCl
MDL No. :MFCD30489757
InChI Key :SCQDMKUZHIGAIB-UHFFFAOYSA-N
Pubchem ID :71295844

Safety of Laduviglusib monohydrochloride

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Laduviglusib monohydrochloride

PI3K-AKT
Hedgehog

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293T cells 5 or 10 μM Activate Wnt/β-catenin signaling to a level similar to Wnt plus R-spondin1 PMC6120946
B cells 10 µM 48 h Induce IL-10+ Bregs and suppress TNF-α expression PMC11638867

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.99mL

0.40mL

0.20mL

9.96mL

1.99mL

1.00mL

19.93mL

3.99mL

1.99mL

References

[1]Mussmann R, Geese M, et al. Inhibition of GSK3 promotes replication and survival of pancreatic beta cells. J Biol Chem. 2007 Apr 20;282(16):12030-7.

[2]Ring DB, Johnson KW, et al. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes. 2003 Mar;52(3):588-95.

[3]Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T, Wagman AS, Hammond ME, Harrison SD. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes. 2003 Mar;52(3):588-95. doi: 10.2337/diabetes.52.3.588. PMID: 12606497.

[4]Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, Hsiao C, Kamp TJ, Palecek SP. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat Protoc. 2013 Jan;8(1):162-75. doi: 10.1038/nprot.2012.150. Epub 2012 Dec 20. PMID: 23257984; PMCID: PMC3612968.

[5]Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, Raval KK, Zhang J, Kamp TJ, Palecek SP. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):E1848-57. doi: 10.1073/pnas.1200250109. Epub 2012 May 29. PMID: 22645348; PMCID: PMC3390875.

[6]Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J, Cohen P, Smith A. The ground state of embryonic stem cell self-renewal. Nature. 2008 May 22;453(7194):519-23. doi: 10.1038/nature06968. PMID: 18497825; PMCID: PMC5328678.

 

Historical Records

Categories